Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

176.59
Delayed Data
As of Jul 31
 +4.90 / +2.85%
Today’s Change
124.76
Today|||52-Week Range
181.81
+10.86%
Year-to-Date

Today’s Trading

Previous close171.69
Today’s open177.50
Day’s range176.00 - 181.81
Volume7,289,406
Average volume (3 months)3,291,487
Market cap$134.3B
Dividend yield1.79%
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+10.56%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+7.30%
P/E ratio23.8
Price/Sales6.12
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.04-0.03%
BIIBBiogen+1.78+0.56%
BXLTBaxalta Inc+0.92+2.88%
BAXBaxter International...+0.07+0.17%
Data as of 4:02pm ET, 07/31/2015

Financials

Last reporting dateJuly 30, 2015
EPS forecast (this quarter)$2.43
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts